Cargando…
Serum Paraoxonase-1 Activity in Prostate Cancer Patients Treated with Brachytherapy as a Measure of Irradiation Efficacy
We investigated changes in the activity of antioxidant paraoxonase-1 (PON1) in patients with prostate cancer (PCa) undergoing radiotherapy (RT), as well as the relationship of the PON1 activity with the degree of PCa advancement. We included 84 men with PCa. Blood samples were obtained before irradi...
Autores principales: | Olszewska-Słonina, Dorota, Jasiński, Miłosz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9951881/ https://www.ncbi.nlm.nih.gov/pubmed/36829771 http://dx.doi.org/10.3390/antiox12020212 |
Ejemplares similares
-
Serum Paraoxonase-1 Activity and the Risk of Prostate Cancer Recurrence in Patients Treated with Radiotherapy
por: Jasinski, Milosz, et al.
Publicado: (2022) -
The concentration of thiobarbituric acid reactive substances (TBARS) and paraoxonase activity in blood of patients with osteoarthrosis after endoprosthesis implantation
por: Olszewska-Słonina, Dorota M., et al.
Publicado: (2011) -
Biomarkers could facilitate prediction of worse clinical outcome of cancer with special insight to cervical cancer
por: Czerniak, Bartosz, et al.
Publicado: (2018) -
Sperm cyropreservation and oxidative damage. What does it mean?
por: Olszewska–Slonina, Dorota
Publicado: (2013) -
Serum paraoxonase activity in familial hypercholesterolaemia
por: Kotani, Kazuhiko, et al.
Publicado: (2023)